Companies: 10,795·Total market cap: $144.5T
Thorne HealthTech, Inc.

Thorne HealthTech, Inc.

THRNNASDAQConsumer Defensive
$10.19
$-0.01(-0.10%)
Market Cap$550634992
P/E Ratio
52W High$10.2
52W Low$3.41
Overview

Thorne HealthTech, Inc. (THRN) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · THRN · as of Jun 9, 2026

Key Statistics

EPS (TTM)thrn eps ttm · thrn earnings per shareEarnings history
PE Ratio (TTM)thrn pe ratio ttm · thrn price to earningsPE Ratio deep dive
Revenue (TTM)thrn revenue ttm · thrn annual revenueFull revenue history
Dividend YieldNo Dividenddoes thrn pay dividends · thrn dividend yieldDividend history
Shares Outstandingthrn shares outstanding · thrn floatShares outstanding history
Next EarningsTBAthrn earnings date · thrn next earningsEarnings history

About Thorne HealthTech, Inc.

CEOPaul F. Jacobson
IPO DateSep 23, 2021
Employees544
CountryUS
Websitethorne.com

Thorne HealthTech, Inc. is a scientifically-driven wellness enterprise that offers customized health solutions to clients both within the United States and globally. Their extensive portfolio includes…

what is thorne healthtech, inc. · thrn stock overview · thorne healthtech, inc. company profile · who is thorne healthtech, inc. ceo · thrn NASDAQ · thorne healthtech, inc. headquarters · thorne healthtech, inc. business segments

About Stock Overview & Key Data

Thorne HealthTech, Inc. (THRN) is a Consumer Defensive company in the Packaged Foods industry, listed on NASDAQ since Sep 23, 2021. As of the latest trading session, THRN stock price is $10.19, with a market capitalization of $550.6M. The stock has returned — over the past 12 months and — year-to-date.

Frequently Asked Questions

As of the latest trading session, Thorne HealthTech, Inc. (THRN) stock price is $10.19. The stock is traded on NASDAQ under the ticker symbol THRN. The 52-week range is $3.41 – $10.20.

THRN stock priceTHRN quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice